According to the latest study titled ‘Platelet Aggregation Devices Market Share, Size, Trends, Industry Analysis Report, By Product; By Application ; By End Use; By Regions; Segment Forecast, 2020 -2027’, available with Market Study Report, global platelet aggregation devices industry is anticipated to amass USD 1556.8 million by the year 2026.
 

Rising prevalence of chronic ailments such as leukemia, myelodysplastic syndrome (MDS), and kidney failure (uremia) leading to platelet dysfunction, in consort with drastic surge in infectious disease cases due to advent of Covid-19 pandemic are primarily driving the growth of global platelet aggregation devices market. Moreover, introduction of innovative systems, mechanisms, and consumables in the field is providing impetus to industry growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2963826/
 

For the unversed, platelet aggregation is a biological process which helps in constraining bleeding by rapid clot formation. Qualitative and quantitative platelet defects lead to thromboembolic complications, hence resulting in increased bleeding. The platelet dysfunction can either be inherited or acquired. Various tests for detecting platelet aggregation are flow cytometry, lumi-aggregometry, whole blood impedance aggregometry (WBA), and light transmission aggregometry (LTA).
 

Increasing usage of automated hematology analyzers for platelet count, and acceptance of screening tests like activated partial thromboplastin time (aPTT) and prothrombin time (PT) are stimulating worldwide platelet aggregation devices market outlook.
 

Based on product terrain, the marketplace is segmented into accessories, consumables, reagents, and systems. Speaking application scope, the industry is categorized into clinical applications, and research applications among others. Various end-users include blood banks, research & academic institutes, diagnostic laboratories, and standalone hospitals.
 

Well-known players in global platelet aggregation devices market sphere are Sienco Inc., Haemonetics Corporation, Aggredyne Inc., Sentinel CH. S.p.A., Helena Laboratories Corp., Drucker Diagnostics Inc., Accriva Diagnostics (acquired by Instrumentation Laboratory), Siemens Healthineers AG, Sysmex Corporation, and F. Hoffmann La-Roche AG.